Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Photochem Photobiol B ; 78(1): 43-51, 2005 Jan 14.
Article in English | MEDLINE | ID: mdl-15629248

ABSTRACT

The current study evaluates the efficacy of Balsamodendron mukul Hook ex. Stocks, an indigenous plant, in the modulation of benzoyl peroxide (BPO) treated and ultraviolet (UV) light irradiated tumor promotional events. BPO is a well-known tumor promoter while UV radiations are capable of acting as complete carcinogens. Treatment of the dorsal portions of the mice skins with BPO (20 mg/0.2 ml/animal) and subsequent UV irradiation (0.420 J/m(2)/s) caused a significant depletion of reduced glutathione (GSH), it's metabolizing and phase II enzymes (p < 0.01). Also, down regulation of the activities of antioxidant enzymes and up regulation of ornithine decarboxylase activity and enhancement in the synthesis of DNA, malondialdehyde (MDA) and hydrogen peroxide (H(2)O(2)) was observed. However, topical pretreatment with the extract of B. mukul not only restored the content of GSH, MDA and H(2)O(2) but it also recovered the activities of above-mentioned enzymes (p < 0.05) and prevented synthesis of DNA (p < 0.05) significantly. Although the lower dose was not very effective, the higher dose showed promising results against oxidative stress and hyperproliferative response of BPO and UVB radiations. From the present data we conclude that B. mukul is potentially strong enough to modulate the events of skin tumor promotion.


Subject(s)
Benzoyl Peroxide/antagonists & inhibitors , Neoplasms/chemically induced , Neoplasms/drug therapy , Plant Extracts/pharmacology , Ultraviolet Rays , Animals , Antioxidants/metabolism , Benzoyl Peroxide/pharmacology , Female , Glutathione/metabolism , Hydrogen Peroxide/metabolism , Lipid Peroxidation/drug effects , Lipid Peroxidation/radiation effects , Mice , Neoplasms/pathology , Phytotherapy , Plant Extracts/therapeutic use , Skin/drug effects , Skin/metabolism , Skin/radiation effects
2.
Toxicol Lett ; 153(3): 293-302, 2004 Nov 28.
Article in English | MEDLINE | ID: mdl-15454305

ABSTRACT

The present study was carried out to study the effect of gentisic acid (2,5-dihydroxybenzoic acid (2,5-DHBA)) on the tumor promotion related events of carcinogenesis in murine skin. Benzoyl peroxide (BPO) (20 mg/0.2 ml/animal) and ultraviolet radiations (UVR) (0.420 J/m2/s) were used to induce tumor promotion response and oxidative stress and caused significant depletion in the detoxification and antioxidant enzyme armory with concomitant elevation in malondialdehyde (MDA) formation, hydrogen peroxide (H2O2) generation, ornithine decarboxylase (ODC) activity and unscheduled DNA synthesis. However, gentisic acid pretreatment at two different doses restored the levels of the above said parameters (P < 0.05) in a dose-dependent manner except in the case of ODC activity. Therefore, we propose that it might suppress the promotion stage via inhibition of oxidative stress but may not affect the polyamine biosynthetic pathway.


Subject(s)
Benzoyl Peroxide/antagonists & inhibitors , Benzoyl Peroxide/toxicity , Gentisates/pharmacology , Keratolytic Agents/toxicity , Neoplasms, Radiation-Induced/prevention & control , Skin Neoplasms/prevention & control , Animals , Catalase/metabolism , DNA/biosynthesis , DNA/genetics , Female , Glucosephosphate Dehydrogenase/metabolism , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Glutathione Reductase/metabolism , Glutathione Transferase/metabolism , Hydrogen Peroxide/metabolism , Lipid Peroxidation/drug effects , Lipid Peroxidation/radiation effects , Mice , NAD(P)H Dehydrogenase (Quinone)/metabolism , Neoplasms, Radiation-Induced/pathology , Ornithine Decarboxylase/metabolism , Proteins/metabolism , Skin Neoplasms/etiology , Skin Neoplasms/pathology , Ultraviolet Rays
3.
Pharmacol Res ; 43(2): 127-34, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11243713

ABSTRACT

The modulating effect of Lupeol [lup-20(29)-en-3 beta -ol], a triterpene found in many fruits and medicinal plants, on benzoyl peroxide-induced tumor promotion responses or tumor promotion in murine skin is described. Benzoyl peroxide is an effective cutaneous tumor promoter acting through the generation of oxidative stress, the induction of ornithine decarboxylase activity and the enhancement of DNA synthesis. Benzoyl peroxide treatment increases cutaneous microsomal lipid peroxidation and hydrogen peroxide generation. The activity of the cutaneous antioxidant enzymes, namely catalase, glutathione peroxidase, glutathione reductase and glutathione S-transferase, is decreased and levels of cutaneous glutathione are depleted. Benzoyl peroxide treatment also induces ornithine decarboxylase activity and enhances [3H]thymidine uptake in DNA synthesis. Prophylactic treatment of mice with lupeol (0.75 and 1.5 mg per animal) 1 hour before benzoyl peroxide treatment resulted in a diminution of benzoyl peroxide-mediated damage. The susceptibility of cutaneous microsomal membrane to lipid peroxidation and hydrogen peroxide generation was significantly reduced (P< 0.01 and P< 0.01, respectively). In addition, depleted levels of glutathione and inhibited activity of antioxidant enzymes were recovered to a significant level (P< 0.01, P< 0.05 and P< 0.01, respectively). Similarly, the elevated ornithine decarboxylase activity and enhanced thymidine uptake in DNA synthesis were inhibited significantly (P< 0.05) in a dose-dependent manner. The protective effect of lupeol was dose dependent in all parameters. The results suggest that lupeol is an effective skin chemopreventive agent that may suppress benzoyl peroxide-induced cutaneous toxicity.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Glutathione/drug effects , Lipid Peroxidation/drug effects , Ornithine Decarboxylase/drug effects , Oxidative Stress/drug effects , Triterpenes/pharmacology , Animals , Anti-Inflammatory Agents/therapeutic use , Benzoyl Peroxide/antagonists & inhibitors , Carcinogens/antagonists & inhibitors , Catalase/drug effects , Catalase/metabolism , Glucosephosphate Dehydrogenase/drug effects , Glucosephosphate Dehydrogenase/metabolism , Glutathione/metabolism , Lipid Peroxidation/physiology , Male , Mice , Ornithine Decarboxylase/metabolism , Oxidative Stress/physiology , Pentacyclic Triterpenes , Skin/drug effects , Skin/enzymology , Triterpenes/therapeutic use
4.
Food Chem Toxicol ; 38(10): 939-48, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11039327

ABSTRACT

The modulating effect of spearmint (Mentha spicata) on benzoyl peroxide-induced responses of tumor promotion in murine skin was investigated. Benzoyl peroxide (BPO) is an effective cutaneous tumor promoter acting through the generation of oxidative stress, induction of ornithine decarboxylase activity and by enhancing DNA synthesis. BPO treatment (20 mg/animal) increased cutaneous microsomal lipid peroxidation and hydrogen peroxide generation. The activity of cutaneous antioxidant enzymes, namely catalase, glutathione peroxidase, glutathione reductase and glutathione S-transferase, was decreased and the level of cutaneous glutathione was depleted. BPO treatment also induced the ornithine decarboxylase activity and enhanced the [3H]thymidine uptake in DNA synthesis in murine skin. Prophylactic treatment of mice with spearmint extract (10, 15 and 20 mg/kg) 1 hr before BPO treatment resulted in the diminution of BPO-mediated damage. The susceptibility of cutaneous microsomal membrane to lipid peroxidation and hydrogen peroxide generation was significantly reduced (P < 0.05 ). In addition, depleted levels of glutathione, inhibited activity of glutathione dependent and antioxidant enzymes were recovered to a significant level (P < 0.01, P < 0.05 and P < 0.01, respectively). Similarly, the elevated ornithine decarboxylase activity and enhanced thymidine uptake in DNA synthesis was inhibited significantly (P < 0.05 ) in a dose-dependent manner. The protective effect of spearmint was dose dependent in all parameters. The result suggests that spearmint is an effective chemopreventive agent that may suppress BPO-induced cutaneous oxidative stress, toxicity and hyperproliferative effects in the skin of mice.


Subject(s)
Benzoyl Peroxide/antagonists & inhibitors , Benzoyl Peroxide/toxicity , Carcinogens/antagonists & inhibitors , Carcinogens/toxicity , Lamiaceae/chemistry , Oxidative Stress/drug effects , Skin/metabolism , Animals , Catalase/metabolism , Cell Division/drug effects , DNA/biosynthesis , DNA/genetics , Female , Glucosephosphate Dehydrogenase/metabolism , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Glutathione Reductase/metabolism , Glutathione Transferase/metabolism , Hydrogen Peroxide/metabolism , Mice , Ornithine Decarboxylase/metabolism , Oxidation-Reduction , Plant Extracts/pharmacology , Skin/chemistry , Skin/drug effects
5.
Chem Biol Interact ; 122(2): 89-106, 1999 Sep 30.
Article in English | MEDLINE | ID: mdl-10528995

ABSTRACT

The effects of topical applications of 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-[2,3-b]quinoxaline (B-220), on 12-O-tetradecanoylphorbol-13-acetate (TPA) or benzoylperoxide (BPO) induced promotion of skin tumors and hyperplasia were studied in female SENCAR mice. Papillomas were induced by initiation with 7,12-dimethylbenz[a]anthracene (DMBA), followed by promotion biweekly with TPA or BPO. Administration of B-220 1 h before TPA promotion resulted in a prolonged latency period of tumor appearance and a significantly reduced (up to 15% of positive controls) papilloma yield at 20 weeks. Moreover, if B-220 treatment was terminated after 20 weeks and TPA treatment continued, papilloma development resumed indicating that initiated tumor cells were still present but were unable to grow with B-220 present. If B-220 pretreatment was not given during the first 10 weeks of TPA promotion, incidence at 20 weeks was not reduced but tumor multiplicity was still decreased. In addition a marked reduction of the TPA induced sustained epidermal hyperplasia was observed in the long term experiment. Neither the inflammatory response nor the increase in the number of apoptotic cells seen in short term experiment after a single TPA treatment were inhibited by B-220. B-220 administration before BPO promotion had no effect on the appearance of BPO induced papillomas or epidermal hyperplasia, suggesting that TPA and BPO promote tumor formation via at least partially different mechanisms. In experiments where B-220 was applied topically 1 h before DMBA initiation, little or no effect was seen. No morphological changes in mouse skin due to long term exposure (two times/week, 39 weeks) to B-220 were found. In conclusion, we present evidence that B-220 is a potent inhibitor of mouse skin tumor promotion by TPA, but has little effect on the initiation step or the survival of initiated cells.


Subject(s)
Indoles/therapeutic use , Precancerous Conditions/prevention & control , Quinoxalines/therapeutic use , Skin Neoplasms/prevention & control , Skin/pathology , Tetradecanoylphorbol Acetate/antagonists & inhibitors , 9,10-Dimethyl-1,2-benzanthracene/antagonists & inhibitors , 9,10-Dimethyl-1,2-benzanthracene/toxicity , Animals , Anticarcinogenic Agents/pharmacology , Benzoyl Peroxide/antagonists & inhibitors , Benzoyl Peroxide/toxicity , Carcinogens/toxicity , Dermatitis, Contact/etiology , Female , Hyperplasia , Mice , Mice, Inbred SENCAR , Precancerous Conditions/chemically induced , Precancerous Conditions/pathology , Skin/drug effects , Skin Neoplasms/chemically induced , Skin Neoplasms/pathology , Tetradecanoylphorbol Acetate/toxicity
6.
Biomaterials ; 18(9): 701-3, 1997 May.
Article in English | MEDLINE | ID: mdl-9152003

ABSTRACT

This study was undertaken to examine an effect of eugenol on polymerization of methyl methacrylate (MMA) by benzoyl peroxide (BPO) and 2,2'-azobisisobutyronitrile (AIBN) in the presence of eugenol. The induction period and initial rate of polymerization (IRP) were determined from polymerization curves of MMA using differential scanning calorimetry (DSC). The induction period increased with increasing concentration of eugenol in both BPO and AIBN systems. The IRP decreased as the concentration of eugenol in both BPO and AIBN systems. The IRP decreased as the concentration of eugenol increased. Its decreasing rate in the BPO system was higher than that in the AIBN system. In the BPO system, the IRP was reduced to zero at 0.5 mol% of eugenol. Eugenol in the BPO system was an efficient retarder, although the decrease in IRP was relatively small, below 0.05 mol%. Eugenol was an inhibitor even at high concentration in the AIBN system. The suppressible effect of eugenol appears to be due to the interaction between free radicals from BPO and eugenol.


Subject(s)
Benzoyl Peroxide/antagonists & inhibitors , Eugenol/pharmacology , Methylmethacrylates/chemistry , Polymers/chemistry , Benzoyl Peroxide/chemistry , Bone Cements , Colloids , Eugenol/chemistry , Kinetics , Methylmethacrylate , Nitriles/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...